COMPANY 

INSIGHT

High precision, low friction and low energy consumption

With headquarters located in Biel/Bienne Switzerland, MPS Micro Precision Systems AG develops and manufactures highly complex and very precise mechanical and electro-mechanical microsystems used in the Medtech, Automation and Watch industries. In a spacious and modern architecture the 400 employees of MPS transform customer requirements and specifications into robust and reliable products and systems.

MPS supplies to a Blue Chip Medtech company in the US the dosing system for a programmable implantable infusion pump. The pump’s main requirement is to deliver a specific amount of medication using the energy stored in an embedded battery. To guarantee this requirement over the entire lifetime of the product (7 years), MPS has optimised a very precise implantable microsystem which performs the function with nearly no friction and therefore minimal energy consumption.

Spine surgery is a very delicate operation, with success depending on the individual performance of the surgeon. MPS manufactures a small and very precisely adjustable spine surgery assist robot (positioning precision = 1µm), which makes the accuracy of the surgical procedure less dependent on the surgeon’s daily performance.

Biocompatible actuators

MPS’ biocompatible actuator technology consists of an encapsulated motor, electronics and power element, as well as a gearbox and leadscrew made of biocompatible materials. The actuators and electronics are designed for long term implantation and for wireless data and energy transfer. This technology has a wide range of applications in the orthopaedic, spine, CMF, urology and other markets.

Miniaturisation

Integrating as much functionality as possible into the smallest available space is a key competence of MPS and a requirement of the market for active implants. MPS engineers are combining their know-how in micro bearing technologies, the know-how of their parent company Faulhaber in micro motors and gear boxes and the competences of their electronic partner in order to develop and manufacture implantable, intelligent microsystems featuring low energy consumption.

Very high precision component manufacturing and system assembly in clean environment

Very precise components are at the heart of MPS’ microsystems. These components are manufactured at MPS own workshops in Biel/Bienne: Swiss turning, flat, round and centerless grinding as well as polishing yield components with tolerances lower than 1µm and to a surface roughness of less than 0.1 Ra. MPS is also well equipped for heat treatment and component cleaning.

Very impressive are MPS’s microsystems assembly capabilities: in order to reach the required repeatable precision and the lowest possible friction by keeping system stiffness, MPS has developed its own assembly processes and capabilities. Using MPS made assembly benches and jigs, the operators pair components to a precision of less than 0.2 µm in series production. Depending on the requirements, system assembly is taking place either in a dust free room or in a clean room ISO class 7.

Technical files

MPS project / product documentation conform to CE standards, 510k and PMA requirements. MPS customers may use this documentation to complete their submission dossier.

Orthopaedic instruments

Since December 2012 MPS has a new subsidiary named “MPS Precimed” located at Corgémont in the Bern Jura. With its 90 employees MPS Precimed develops and manufactures innovative orthopaedics instruments for the main Blue Chip orthopaedic companies. Reamers, impactors and drills are part of MPS Precimed’s product portfolio.

Go to article: Home | Regulation: ready for the digital age?Go to article: In this issueGo to article: TelemedGo to article: Telemed Company InsightGo to article: ContentsGo to article: ARPAGo to article: NewsGo to article: Tricor SystemsGo to article: Will automation take over healthcare jobs? Industry experts share their opinionGo to article: MikronGo to article: Is regulation ready for the rise of digital health products?Go to article: Scandinavian Health Ltd Company insightGo to article: Scandinavian Health LtdGo to article: Laboratory-developed tests are under the regulatory spotlightGo to article: Micro Systems Technologies Management AGGo to article: 23andMe's at-home genetic test is now approved for breast cancerGo to article: Art of TechnologyGo to article: FDA approves first AI device to detect diabetic retinopathyGo to article: BISAGo to article: New wearable MRI scanner could read your mindGo to article: Frankfurt Laser CompanyGo to article: Frankfurt Laser Company | Company InsightGo to article: Rising number of surgical procedures to drive sutures market to $4.5bn by 2024Go to article: FormacoatGo to article: Formacoat Company InsightGo to article: Med Tech trade post-Brexit: it's time to take actionGo to article: MPS Microsystems Go to article: MPS Microsystems Company InsightGo to article: Inside the UK's new healthcare photonics centreGo to article: raPHARMGo to article: Virtual surgery: the healthcare potential of augmented realityGo to article: Alpha TechnicsGo to article: Upcoming events for the medical devices industryGo to article: AerotechGo to article: Event: AchemaGo to article: Nelson LabGo to article: Event: EPHJ-EPMT-SMTGo to article: AccumoldGo to article: Next issue previewGo to article: Maraca International